Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug;93(2):466-468.
doi: 10.1016/j.jaad.2025.03.047. Epub 2025 Mar 21.

Rapid clinical response to nemolizumab in dermatologic diseases associated with pruritus and burning: A multicenter case series

Emi M Murase  1 , Ajay S Dulai  2 , Sammer Marzouk  3 , Peter A Lio  3 , Raja K Sivamani  4 , Jenny E Murase  5
Affiliations

Rapid clinical response to nemolizumab in dermatologic diseases associated with pruritus and burning: A multicenter case series

Emi M Murase et al. J Am Acad Dermatol. 2025 Aug.
No abstract available

Keywords: acquire brachioradial pruritus; atopic dermatitis; burning; burning mouth syndrome; cutaneous mastocytosis; erythromelalgia; immunologic eruptions of aging; leukemia; lichen amyloidosis; lymphoma; mycosis fungoides; nemolizumab; neurogenic rosacea; neuropathic itch; neuropathic pain; prurigo; pruritus; urticaria.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest Dr E. Murase: Speaker bureau for Regeneron, Genzyme/Sanofi, Galderma, and UCB; advisory boards for Regeneron, Genzyme/Sanofi, UCB, Arcutis, and Bristol Myers Squibb; consulting for AbbVie, UCB, Sanofi-Regeneron and UpToDate. Dr Sivamani is a Scientific advisor for LearnHealth, Arbonne, Trace Minerals, and Codex Labs; consultant or speaker for Burt's Bees, Image Skincare, Novartis, Sanofi, Bristol Myers Squibb, Pfizer, Nutrafol, Lilly, Galderma, Incyte, Abbvie, Leo, UCB, Sun and Regeneron Pharmaceuticals. Dr Lio is a speaker's bureau for AbbVie, Arcutis, Eli Lilly, Galderma, Hyphens Pharma, Incyte, La Roche-Posay/L'Oreal, Pfizer, Pierre-Fabre Dermatologie, Regeneron/Sanofi Genzyme, Verrica; reports consulting/advisory boards for Alphyn Biologics (stock options), AbbVie, Almirall, Amyris, Arcutis, ASLAN, Bristol-Myers Squibb, Burt's Bees, Castle Biosciences, Codex Labs (stock options), Concerto Biosci (stock options), Dermavant, Eli Lilly, Galderma, Janssen, LEO Pharma, Lipidor, L'Oreal, Merck, Micreos, MyOR Diagnostics, Regeneron/Sanofi Genzyme, Sibel Health, Skinfix, Suneco Technologies (stock options), Theraplex, UCB, Unilever, Verdant Scientific (stock options), Verrica, Yobee Care (stock options); patent pending for a Theraplex product with royalties. Drs Dulai, M. Murase, and Author Marzouk have no conflicts of interest to declare.